TIF
An educational leaflet with important information for β-thalassaemia patients on hematopoietic stem cell transplantation (HSCT), more commonly known as bone marrow transplantation (BMT).
Latest News:
- The future of genome editing in Europe – Bringing together the views of government, industry, patient communities, and civil society’ representatives
- TIF joined the Celgene’s Blood Transfusion Round Table Discussion in Brussels
- TIF welcomes landmark UN declaration on Universal Health Coverage
- The Greek Thalassaemia Federation hosts its annual Educational Conference on September 20-22
- Hypertension Medication Valsartan May Help Prevent Vaso-Occlusive Episodes in Sickle Cell Disease
